medigraphic.com
ISSN 0016-3813 (Print)

2003, Number 2

<< Back Next >>

Gac Med Mex 2003; 139 (2)

Viral Diseases in Hematology

I. Viral Diseases in Hematology.

Góngora-Biach RA

Language: Spanish
References: 38
Page: 102-105
PDF size: 48.29 Kb.


Text Extraction

No abstract


REFERENCES

  1. Mc Nall RY, Head DR, Pui CH, Razzouk BI. Parvovirus B19 infection in a child with acute linphoblastic leukemia during induction therapy. Am J. Pediatr Hematol 2001;23: 309-311.

  2. Pamidi S, Friedman K, Kampalath B, Eshoa C, Hariharan S. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000, 69: 266-269

  3. Serjeant BE, Hambleton IR, Kerr S, Kitty CG, Serjeant GR. Haematological response to parvovirus B19 infection in homozygous sickle- cell disease. Lancet 2001; 358:1779-1780.

  4. Veprekova L, Jelinek J, Zeman J. Congenital aplastic anemia caused by parvovirus B19 infection. Cas Lek Cesk 2001; 140:178-180.

  5. Qian XH, Zhang GC, Jiao XY, Zheng YJ, Cao YH, Xu DL, et al. Aplastic anaemia associated with parvovirus B19 infection. Arch Dis Child 2002; 87:436-437.

  6. Dame C, Hasan C, Bode U, Eis-Hubinger AM. Acute liver disease and aplastic anemia associated with the persistence of B19 DNA in liver and bone marrow. Pediatr Pathol Mol Med 2002; 21:25-29.

  7. Tung J, Hadzic N, Layton M, Baker AJ, Dhawan A, Rela M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr 2000; 31:557-561.

  8. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000; 96:1184-1186.

  9. Song KW, Mollee P, Patterson B, Brien W, Crump M. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol 2002; 119:125-127.

  10. Safadi R, Or R, Ilan Y, Naparstek E, Nagler A, Klein A, et al. Lack of kwon hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001; 27:183-190.

  11. Bozkaya H, Yurdaydin C, Toruner M, Arat M, Bozdayi AM, Erekul S, et al. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine. Dig Dis Sci 2002; 47:1782-1785.

  12. Udonsakdi-Auerwarakul C, AuewarakulP, Pempikul P, Issaragrisil S. TT virus infection in Thailand: prevalence in blood donors and patients with aplastic anemia. Int J Hematol 2000; 72:325-328.

  13. Itterbeek P, Vanderberghe P, Nevens F, Fevery J, Aerts R, Yap SH, et al. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int 2002; 15:117-123.

  14. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol 2000; 71:108-117.

  15. Timms JM, Bell A, Flavell JR, Murray PG, Rickinson AB, Traverse-Glehen A, et al. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin’s lymphoma. Lancet 2003; 361:217-223.

  16. Quintanilla-Martinez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, et al. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A. Mod Pathol 1988; 11:200-208.

  17. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, Gschwendter A, Gredler E, Reyes E, et al. Primary non-Hodgkin’s lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997; 89:644-651.

  18. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, Gschwendter A, Gredler E, Angeles-Angeles A, et al. Primary intestinal non-Hodgkin’s lymphoma and Epstein-Barr virus: high frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leuk Lymphoma 1998; 30:111-121.

  19. Jarrett RF, MacKenzie J. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin’s disease. Semin Hematol 1999; 36:260-269.

  20. Monterroso V, Zhou Y, Koo S, Glackin C, Bujan W, Medeiros LJ. Hodgkin’s disease in Costa Rica: a report of 40 cases analyzed for Epstein-Barr virus. Am J Clin Pathol 1998; 109:618-624.

  21. Zarate-Osorno A, Roman LN, Kingma DW, Meneses-Garcia A, Jaffe ES. Hodgkin’s disease in Mexico: prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 15:1360-1366.

  22. Quintanilla-Martinez L, Gamboa-Dominguez A, Gamez-Ledesma I, Angeles-Angeles A, Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin’s disease in Mexico. Mod Pathol 1995; 8:675-679.

  23. Dimhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, Reyes E, Gredler E, Krugmann J, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin’s disease and reactive lymphoid tissue. Hum Pathol 1999; 30:781-787.

  24. Levine AM. Hodgkin’s disease in the setting of human immunodeficiency virus infection. J Natl Cancer Inst 1998; 23:37-42.

  25. Aboulafia D. Epidemiology and pathogenesis of AIDS-related lymphoma. Oncology 1998; 12:1068-1081.

  26. Patel M, Mahlangu J, Patel J, Stevens G, Stevens W, Allard U, Mendelow B. Kaposi sarcoma-associated herpesvirus/human herpesvirus8 and multiple myeloma in South Africa. Diagn Mol Pathol 2001; 10:95-99.

  27. Drabick JJ, Davis BJ, Lichy JH, Flynn J, Burd JC. Human herpesvirus 8 genome is not found in whole bone marrow core biopsy specimen of patients with plasma cell dyscrasias. Ann Hematol 2002; 81:304-307.

  28. Belec L, Mohamed AS, Authier FJ, Hallouin MC, Soe AM, Cotigny S, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman’s disease. Blood 1999; 93:3643-3653.

  29. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et al. High incidence of kaposi sarcoma-associated herpesvirus-related non.Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002 99:2331-2336.

  30. King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in non-Hodgkin’s lymphoma. Clin Lab Haematol 1998; 20:107-110.

  31. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347:89-94.

  32. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994; 343:213-216.

  33. Murphy EL, Engstrom JW, Miller K. HTLV-II associated myelopathy in 43-year-old woman. Lancet 1993; 341:757-758.

  34. Loughran TP, Coyle T, Sherman MP. Deletion of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992; 80:1116-1119.

  35. Góngora-Biachi RA, González-Martínez P, Puerto-Manzano FI, Sosa-Muñoz J, Duarte-Zapata L, Bastarrachea-Ortiz J, et al. A low prevalence of HTLV-I/II infection among eight population groups from Merida, Yucatan, Mexico. J Acquir Immun Defic Syndr 1992;5:102-105.

  36. Góngora-Biachi RA, González-Martínez P, Puerto-Manzano FI, Yamaguchi K, Nishimura Y, Takatsuki K. Micosis fungoide asociada al virus linfotrópico de células T humanas en Yucatán. Rev Invest Clin 1991; 43: 111.

  37. Góngora-Biachi RA, González-Martínez P, Castro-Sansores C, Lara-Perera D, Valadez-González N. Leucemia Linfocítica Crónica de Células T Asociada a infección por el Virus Linfotrópico de Celúlas T Humanas Tipo II (HTLV-II) (Abstr). Enf Infec Microbiol 1999; 19:S69.

  38. Gongora-Biachi RA, Gonzalez-Martinez P, Castro-Sansores C, Pavia-Ruz N, Donna RL, Renu BL. Human T Lymphotropic virus type II ( HTLV-II ) infection among female prostitutes in Yucatan, Mexico. Am J Med Sci 1993; 306:207-211.




2020     |     www.medigraphic.com